Court Dismisses Failure-To-Warn Claim in Wrongful Death Suit Brought Against Drug Manufacturer

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Court Dismisses Failure-To-Warn Claim in Wrongful Death Suit Brought Against Drug Manufacturer

Dennis Tosh

February 26, 2025 at 04:39 PM EST

A federal district court in Massachusetts has dismissed a wrongful death suit brought by the mother of a patient suffering from migraines who experienced a seizure following his treatment with an injectable drug that had been approved by the FDA the previous month (Warner v. Amgen Inc., No. 1:24-cv-10632-JEK, 2025 U.S. Dist. LEXIS 26141, 2025 WL 490720 (D. Mass. Feb. 13, 2025)... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Court Dismisses Failure-To-Warn Claim in Wrongful Death Suit Brought Against Drug Manufacturer

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT